Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 5, 2021

Primary Completion Date

September 1, 2022

Study Completion Date

March 1, 2023

Conditions

Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

Nicotinamide mononucleotide (NMN-C)

Daily supplementation with NMN-C at 400 mg for 29 days in total

Trial Locations (1)

Vitalabs Clinic, Toronto

All Listed Sponsors

collaborator

Dicentra Inc.

INDUSTRY

collaborator

LGD

INDUSTRY

lead

Seneque SA

INDUSTRY

NCT04910061 - Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults. | Biotech Hunter | Biotech Hunter